Heart rate variability, insulin resistance, and insulin sensitivity in Japanese adults: The Toon Health Study

Journal of Epidemiology

Volumn 25, Issue 9, 2015, Pages 583-591

  Saito, Isao ^a   Hitsumoto, Shinichi ^b   Maruyama, Koutatsu ^c   Nishida, Wataru ^a   Eguchi, Eri ^d   Kato, Tadahiro ^e   Kawamura, Ryoichi ^a   Takata, Yasunori ^a   Onuma, Hiroshi ^a   Osawa, Haruhiko ^a   Tanigawa, Takeshi ^f  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b EHIME UNIVERSITY HOSPITAL   (Japan)

^c EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

^e EHIME UNIVERSITY   (Japan)

^f JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Epidemiology; Glucose intolerance; Heart rate variability; Insulin sensitivity

Indexed keywords

GLUCOSE BLOOD LEVEL; INSULIN;

ADULT; AGED; ANALYSIS; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; BODY MASS; CROSS-SECTIONAL STUDY; DIABETES MELLITUS, TYPE 2; ETHNOLOGY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEART; HEART RATE; HUMAN; INSULIN RESISTANCE; JAPAN; LIFESTYLE; MALE; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEART; HEART RATE; HUMANS; INSULIN; INSULIN RESISTANCE; JAPAN; LIFE STYLE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS;

EID: 85000450811     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.JE20140254     Document Type: Article

References (35)

1. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: Systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378:31-40.
2. Kodama K, Tojjar D, Yamada S, Toda K, Patel CJ, Butte AJ. Ethnic differences in the relationship between insulin sensitivity and insulin response: A systematic review and meta-analysis. Diabetes Care. 2013;36:1789-96.
3. Saito I. Epidemiological evidence of type 2 diabetes mellitus, metabolic syndrome, and cardiovascular disease in Japan. Circ J. 2012;76:1066-73.
4. Carnethon MR, Golden SH, Folsom AR, Haskell W, Liao D. Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: The atherosclerosis risk in communities study, 1987-1998. Circulation. 2003;107: 2190-5.
5. Liao D, Carnethon M, Evans GW, Cascio WE, Heiss G. Lower heart rate variability is associated with the development of coronary heart disease in individuals with diabetes: The atherosclerosis risk in communities (ARIC) study. Diabetes. 2002;51:3524-31.
6. Singh JP, Larson MG, Tsuji H, Evans JC, O'Donnell CJ, Levy D. Reduced heart rate variability and new-onset hypertension: Insights into pathogenesis of hypertension: The Framingham heart study. Hypertension. 1998;32:293-7.
7. Dekker JM, Crow RS, Folsom AR, Hannan PJ, Liao D, Swenne CA, et al. Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes: The ARIC study. Atherosclerosis risk in communities. Circulation. 2000;102:1239-44.
8. Gerritsen J, Dekker JM, TenVoorde BJ, Kostense PJ, Heine RJ, Bouter LM, et al. Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: The hoorn study. Diabetes Care. 2001;24:1793-8.
9. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task force of the european society of cardiology and the north american society of pacing and electrophysiology. Eur Heart J. 1996;17:354-81.
10. Laitinen T, Vauhkonen IK, Niskanen LK, Hartikainen JE, Länsimies EA, Uusitupa MI, et al. Power spectral analysis of heart rate variability during hyperinsulinemia in nondiabetic offspring of type 2 diabetic patients: Evidence for possible early autonomic dysfunction in insulin-resistant subjects. Diabetes. 1999;48:1295-9.
11. Festa A, D'Agostino R Jr, Hales CN, Mykkänen L, Haffner SM. Heart rate in relation to insulin sensitivity and insulin secretion in nondiabetic subjects. Diabetes Care. 2000;23:624-8.
12. Bergholm R, Westerbacka J, Vehkavaara S, Seppälä-Lindroos A, Goto T, Yki-Järvinen H. Insulin sensitivity regulates autonomic control of heart rate variation independent of body weight in normal subjects. J Clin Endocrinol Metab. 2001;86:1403-9.
13. Schroeder EB, Chambless LE, Liao D, Prineas RJ, Evans GW, Rosamond WD, et al. Diabetes, glucose, insulin, and heart rate variability: The atherosclerosis risk in communities (ARIC) study. Diabetes Care. 2005;28:668-74.
14. Chang CJ, Yang YC, Lu FH, Lin TS, Chen JJ, Yeh TL, et al. Altered cardiac autonomic function may precede insulin resistance in metabolic syndrome. Am J Med. 2010;123:432-8.
15. Rennie KL, Hemingway H, Kumari M, Brunner E, Malik M, Marmot M. Effects of moderate and vigorous physical activity on heart rate variability in a british study of civil servants. Am J Epidemiol. 2003;158:135-43.
16. Soares-Miranda L, Sandercock G, Vale S, Santos R, Abreu S, Moreira C, et al. Metabolic syndrome, physical activity and cardiac autonomic function. Diabetes Metab Res Rev. 2012;28: 363-9.
17. Thayer JF, Yamamoto SS, Brosschot JF. The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. Int J Cardiol. 2010;141:122-31.
18. Hemingway H, Shipley M, Brunner E, Britton A, Malik M, Marmot M. Does autonomic function link social position to coronary risk? The whitehall ii study. Circulation. 2005;111: 3071-7.
19. Tabara Y, Saito I, Nishida W, Kohara K, Sakurai S, Kawamura R, et al. Relatively lower central aortic pressure in patients with impaired insulin sensitivity and resistance: The toon health study. J Hypertens. 2011;29:1948-54.
20. Nakamura M, Koyama I, Iso H, Sato S, Okazaki M, Kiyama M, et al. Measurement performance of reagent manufacturers by centers for disease control and prevention/cholesterol reference method laboratory network lipid standardization specified for metabolic syndrome-focused health checkups program in Japan. J Atheroscler Thromb. 2009;16:756-63.
21. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183-97.
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9.
23. Gutt M, Davis CL, Spitzer SB, Llabre MM, Kumar M, Czarnecki EM, et al. Validation of the insulin sensitivity index (ISI(0,120)): Comparison with other measures. Diabetes Res Clin Pract. 2000;47:177-84.
24. Ishikawa-Takata K, Naito Y, Tanaka S, Ebine N, Tabata I. Use of doubly labeled water to validate a physical activity questionnaire developed for the Japanese population. J Epidemiol. 2011;21: 114-21.
25. Soonthornpun S, Setasuban W, Thamprasit A, Chayanunnukul W, Rattarasarn C, Geater A. Novel insulin sensitivity index derived from oral glucose tolerance test. J Clin Endocrinol Metab. 2003;88:1019-23.
26. Flaa A, Aksnes TA, Kjeldsen SE, Eide I, Rostrup M. Increased sympathetic reactivity may predict insulin resistance: An 18-year follow-up study. Metabolism. 2008;57:1422-7.
27. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003;26:1553-79.
28. Berkelaar M, EekhoffEM, Simonis-Bik AM, Boomsma DI, Diamant M, Ijzerman RG, et al. Effects of induced hyperinsulinaemia with and without hyperglycaemia on measures of cardiac vagal control. Diabetologia. 2013;56:1436-43.
29. Benthem L, Keizer K, Wiegman CH, de Boer SF, Strubbe JH, Steffens AB, et al. Excess portal venous long-chain fatty acids induce syndrome x via hpa axis and sympathetic activation. Am J Physiol Endocrinol Metab. 2000;279:E1286-93.
30. Hamer M, Steptoe A. Association between physical fitness, parasympathetic control, and proinflammatory responses to mental stress. Psychosom Med. 2007;69:660-6.
31. Cooper TM, McKinley PS, Seeman TE, Choo TH, Lee S, Sloan RP. Heart rate variability predicts levels of inflammatory markers: Evidence for the vagal anti-inflammatory pathway. Brain Behav Immun. 2014. doi:10.1016/j.bbi.2014.12.017.
32. Ribeiro RT, Lautt WW, Legare DJ, Macedo MP. Insulin resistance induced by sucrose feeding in rats is due to an impairment of the hepatic parasympathetic nerves. Diabetologia. 2005;48:976-83.
33. Lautt WW. A new paradigm for diabetes and obesity: The hepatic insulin sensitizing substance (HISS) hypothesis. J Pharmacol Sci. 2004;95:9-17.
34. Boulton AJ, Malik RA. Neuropathy of impaired glucose tolerance and its measurement. Diabetes Care. 2010;33:207-9.
35. Vinik AI, Maser RE, Ziegler D. Autonomic imbalance: Prophet of doom or scope for hope? Diabet Med. 2011;28:643-51.